InvestorsObserver
×
News Home

Is AIM ImmunoTech Inc (AIM) The Right Choice in Biotechnology?

Wednesday, February 10, 2021 10:20 AM | InvestorsObserver Analysts

Mentioned in this article

Is AIM ImmunoTech Inc (AIM) The Right Choice in Biotechnology?

AIM ImmunoTech Inc (AIM) is near the bottom in its industry group according to InvestorsObserver. AIM gets an overall rating of 19. That means it scores higher than 19 percent of stocks. AIM ImmunoTech Inc gets a 10 rank in the Biotechnology industry. Biotechnology is number 18 out of 148 industries.

Overall Score - 19
AIM has an Overall Score of 19. Find out what this means to you and get the rest of the rankings on AIM!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 19 would rank higher than 19 percent of all stocks.

These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With AIM ImmunoTech Inc Stock Today?

AIM ImmunoTech Inc (AIM) stock is trading at $2.88 as of 10:17 AM on Wednesday, Feb 10, an increase of $0.27, or 10.34% from the previous closing price of $2.61. The stock has traded between $2.87 and $3.06 so far today. Volume today is 4,572,569 compared to average volume of 4,331,154.

Click Here to get the full Stock Score Report on AIM ImmunoTech Inc (AIM) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App